NEW YORK, Sept. 16, 2014 /PRNewswire/ -- This report analyzes the worldwide markets for Animal Medication in US$ Million by the following Product Segments: Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report also analyzes the following End-Use Segments: Companion Animals, and Farm Animals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 122 companies including many key and niche players such as -
Abbott Animal Health
Bayer HealthCare
Boehringer Ingelheim GmbH
Ceva Sante Animale S.A
Dechra Pharmaceuticals PLC
Read the full report: http://www.reportlinker.com/p0960410-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions And Scope of Study I-3
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
A Prelude II-1
Table 1: Global Animal Medication Market by Region (2014):
Percentage Market Share Breakdown by Value Sales for North
America, Europe, Latin America and Rest of World (includes
corresponding Graph/Chart) II-1
Importance of Animal Health: A Prelude II-2
Healthy Investments in Veterinary Pharmaceuticals Drives Growth II-2
Table 2: World Animal Healthcare Medication Market by Leading
Players (2014E): Percentage Market Share Breakdown of Leading
Players (includes corresponding Graph/Chart) II-3
Table 3: World Animal Healthcare Products Market by Type
(2014): Percentage Share Breakdown of Revenues for Companion
Animals, Cattle, Pigs, Sheep, and Others (includes
corresponding Graph/Chart) II-4
Thriving Pet Industry - A Major Driver for the Animal
Medication Market II-4
Veterinary Vaccine Market on a High Growth Track II-5
Veterinary Vaccines Market - Demographic Differences and
Market Challenges II-6
Role of Pharmacokinetics in Animal Drug Development II-6
Will the Growing Support for Hormone and Antibiotic Free
Animal Produce Impact the Growth Prospects of the Animal
Medicine? II-7
Impact of the 2007-2009 Recession in Retrospect II-7
Market Challenges Relative to Human Healthcare II-8
2. GROWTH DRIVERS AND MARKET TRENDS II-9
Unmet Animal Health Needs Drives Growth II-9
Table 4: Global Veterinary Healthcare Market: Number of Cases
of Cancer in Cats and Dogs by Geographic Region/Country - US,
Europe and Japan (includes corresponding Graph/Chart) II-9
Need to Ensure Sustainable Food Supply Spurs Growth II-9
Genomics to Influence Development of Animal Medicine in the
Future II-10
Nanotechnology Fast Gaining Ground in Animal Medicine II-10
Human Drugs Trending for Animal Disease Therapies II-11
Advances in Canine Oncology Therapies II-11
Growing Momentum for Post Slaughter Strategies Bodes well for
Animal Medicine II-12
Safety Concerns: An Opportunity Generator II-12
Generics to Attain Major Foothold II-12
Spread of Zoonotic Diseases Propels Growth II-13
Recombinant DNA Technology Boosts the Animal Vaccine Industry II-13
Pet Vaccines Trailing on a High Growth Track in Developing
Countries II-15
Table 5: World Veterinary Vaccines Market (2014): Percentage
Breakdown of Dollar Sales of Vaccines by Product Segment -
Companion (Canine, Feline) and Livestock (Porcine, Bovine,
Poultry, Ovine, Equine and other Animal Vaccines) (includes
corresponding Graph/Chart) II-16
Increasing Demand for Animal Protein in Developing Countries
to Benefit the Market II-16
OTC Market: A Potential Threat for Veterinarians II-16
Pricing Affects Livestock Medication Market II-17
Opportunity Indicators II-17
Table 6: Projected Global Per Capita Consumption of Meat (in
kg per year) by Geographic Region by the year 2030 (includes
corresponding Graph/Chart) II-17
Table 7: Projected Global Consumption of Animal Products (in
million tons) by Developing and Developed Countries for the
year 2030 (includes corresponding Graph/Chart) II-18
The Need for Innovative Vaccine Delivery Mechanism Increasing II-18
Egg-Derived Veterinary Vaccines in Human Vaccine Facilities II-18
Will Plant-Derived Vaccines Hold Potential in Animal Health
Care Industry? II-18
More Vaccines Needed to Prevent Zoonotic Infections II-19
Need to Reduce the Food Print of Food Production Drives Gains II-19
Companion Animals: A High Value Lucrative Market Segment II-19
Animal Health Market Expected to Gain from Antimicrobial
Resistance II-20
Parasitic Vaccines Segment Holds Potential II-20
Demand for Metabolic Modifiers Surging II-21
Marker Vaccines Playing a Vital Role in Disease Detection II-21
Responsible use of Animal Medicines Ignites Interest in Herbal
Alternatives II-21
Challenges in Drug Development Processes II-21
3. PRODUCT OVERVIEW II-22
Animal Medication: An Introduction II-22
Preventive Medicines II-22
Therapeutic Medicines II-22
Others II-22
Considerations II-22
Need for Medications in Companion Animals II-23
Commonly Prescribed (Rx) Animal Health Medications II-23
Non-Prescription Medications II-24
Types of Non-Prescription Medications II-25
Types of Animal Medication II-25
Pharmaceuticals II-25
Medicinal Feed Additives II-25
Biologicals (Excluding Vaccines) II-26
Veterinary Vaccines II-26
Classification of Veterinary Vaccines II-27
Companion Animals Vaccines II-27
Canine Vaccines II-27
Feline Vaccines II-27
Livestock Vaccines II-28
A Tabular Analysis on Select Animal Diseases Controlled by
Vaccines II-28
4. PRODUCT LAUNCHES/INTRODUCTIONS II-29
Novartis Launches Strenzen® II-29
Eco Animal Health's Aivlosin Receives Marketing Approval II-29
Merial Receives FDA Approval for NEXGARD II-29
Boehringer Introduces Semintra for Cats II-29
Nutra Pharma to Launch Pet Pain-Away II-29
Zoetis Receives FDA Approval for APOQUEL® II-29
VetIQ™ Launches Affordable Prescription and OTC Pet Medicines II-30
Elanco Introduces Recuvyra™ II-30
Putney Introduces Simplicef Generic Cefpodoxime Proxetil II-30
Merck Launches Incurin™ Tablets II-30
Pfizer Animal Health Introduces FLUNIXAMINE® and ALVERIN™ PLUS II-30
Merck Animal Health Launches ACTIVYL® and ACTIVYL® Tick Plus
in Europe II-30
5. RECENT INDUSTRY ACTIVITY II-31
Zoetis Reports Shortage of Apoquel Drug II-31
Eli Lilly to Acquire Novartis II-31
Vétoquinol Acquires Bioniche II-31
Aratana to Acquire Vet Therapeutics II-31
Virbac Buys Axon Animal Health II-31
Bayer Integrates Teva Products into its Brand II-31
Perrigo Acquires Velcera II-32
Perrigo Completes Acquisition of Sergeant's II-32
Boehringer to Expand Swine Vaccines Business II-32
Piedmont Pharmaceuticals Inks Agreement with Zhejiang Hisun
Pharmaceutical II-32
Anpario Purchases Meriden Animal Health II-32
Bayer HealthCare Purchases Animal Health Business of KMG
Chemicals II-32
6. FOCUS ON SELECT GLOBAL PLAYERS II-33
Abbott Animal Health (USA) II-33
Bayer HealthCare (Germany) II-33
Boehringer Ingelheim GmbH (Germany) II-33
Ceva Santé Animale S.A. (France) II-34
Dechra Pharmaceuticals PLC (UK) II-34
Eli Lilly and Company (USA) II-35
Merck Animal Health (Netherlands) II-35
Merial Limited (USA) II-36
Novartis Animal Health, Inc. (USA) II-36
Vetericyn, Inc. (USA) II-36
Vétoquinol SA (France) II-37
Virbac SA (France) II-37
Zoetis, Inc. (USA) II-37
7. GLOBAL MARKET PERSPECTIVE II-38
Table 8: World Recent Past, Current and Future Analysis for
Animal Medication Products by Geographic Region/Country - US,
Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-38
Table 9: World Historic Review for Animal Medication Products
by Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-39
Table 10: World 15-Year Perspective for Animal Medication
Products by Geographic Region/Country - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets for Years 2006, 2014,
and 2020 (includes corresponding Graph/Chart) II-40
Table 11: World Recent Past, Current and Future Analysis for
Companion Animal Medication Products by Geographic
Region/Country - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2013
through 2020 (includes corresponding Graph/Chart) II-41
Table 12: World Historic Review for Companion Animal
Medication Products by Geographic Region/Country - US, Canada,
Japan, Europe, Asia-Pacific, Latin America and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-42
Table 13: World 15-Year Perspective for Companion Animal
Medication Products by Geographic Region/Country - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets for
Years 2006, 2014, and 2020 (includes corresponding
Graph/Chart) II-43
Table 14: World Recent Past, Current and Future Analysis for
Farm Animal Medication Products by Geographic Region/Country -
US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-44
Table 15: World Historic Review for Farm Animal Medication
Products by Geographic Region/Country - US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-45
Table 16: World 15-Year Perspective for Farm Animal Medication
Products by Geographic Region/Country - Percentage Breakdown
of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets for Years 2006, 2014,
and 2020 (includes corresponding Graph/Chart) II-46
Table 17: World Recent Past, Current and Future Analysis for
Animal Medication Products by Farm Animal Type - Cattle, Pigs,
and Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-47
Table 18: World Historic Review for Animal Medication Products
by Farm Animal Type - Cattle, Pigs, and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-48
Table 19: World 15-Year Perspective for Animal Medication
Products by Farm Animal Type - Percentage Breakdown of Dollar
Sales for Cattle, Pigs, and Others Markets for Years 2006,
2014, and 2020 (includes corresponding Graph/Chart) II-49
Table 20: World Recent Past, Current and Future Analysis of
Animal Medication Products for Cattle by Geographic
Region/Country - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2013
through 2020 (includes corresponding Graph/Chart) II-50
Table 21: World Historic Review of Animal Medication Products
for Cattle by Geographic Region/Country - US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-51
Table 22: World 15-Year Perspective of Animal Medication
Products for Cattle by Geographic Region/Country - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets for
Years 2006, 2014, and 2020 (includes corresponding
Graph/Chart) II-52
Table 23: World Recent Past, Current and Future Analysis of
Animal Medication Products for Pigs by Geographic
Region/Country - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2013
through 2020 (includes corresponding Graph/Chart) II-53
Table 24: World Historic Review of Animal Medication Products
for Pigs by Geographic Region/Country - US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-54
Table 25: World 15-Year Perspective of Animal Medication
Products for Pigs by Geographic Region/ Country - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets for
Years 2006, 2014, and 2020 (includes corresponding
Graph/Chart) II-55
Table 26: World Recent Past, Current and Future Analysis of
Animal Medication Products for Other Farm Animals by
Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-56
Table 27: World Historic Review of Animal Medication Products
for Other Farm Animals by Geographic Region/Country - US,
Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2006 through 2012 (includes
corresponding Graph/Chart) II-57
Table 28: World 15-Year Perspective of Animal Medication
Products for Other Farm Animals by Geographic Region/Country -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
for Years 2006, 2014, and 2020 (includes corresponding
Graph/Chart) II-58
Table 29: World Recent Past, Current and Future Analysis for
Animal Medication Products by Product Group - Parasiticides,
Vaccines, Anti-Infectives, Medicinal Feed Additives and Others
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-59
Table 30: World Historic Review for Animal Medication Products
by Product Group - Parasiticides, Vaccines, Anti-Infectives,
Medicinal Feed Additives and Others Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) II-60
Table 31: World 15-Year Perspective for Animal Medication
Products by Product Group - Percentage Breakdown of Dollar
Sales for Parasiticides, Vaccines, Anti-Infectives, Medicinal
Feed Additives and Others for Years 2006, 2014, and 2020
(includes corresponding Graph/Chart) II-61
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Veterinary Practitioners Threatened by the Online Pet
Medication Industry III-1
Key Statistical Findings III-2
Table 32: US Pet Healthcare Market (2013 and 2014E):
Percentage Share Breakdown of Annual Consumer Spending on
Pet Health by Type - Food, Grooming, Live animal Purchases,
Medicine, and Vet care (includes corresponding Graph/Chart) III-2
Table 33: US Pet Market (2014): Estimated Pet Population by
Type of Pets - Cats, Dogs, Birds, Horses, Fishes and Others
(includes corresponding Graph/Chart) III-2
Table 34: US Pet Market (2014): Percentage Share Breakdown
of Number of Pets in Each Household (includes corresponding
Graph/Chart) III-3
Table 35: US Pet Market (2014): Percentage Share Breakdown
of Number of Pets in Senior Citizen Households (includes
corresponding Graph/Chart) III-3
Food Safety Concerns and Biotechnological Offerings Drive
the Veterinary Vaccines Market III-3
Dogs and Cats Obesity Vaccines Receive First US Patent III-4
H5N1 Virus: A Conundrum for the US Animal Medication Industry III-4
Regulations III-4
Product Launches III-5
Strategic Corporate Developments III-6
Key Players III-7
B.Market Analytics III-10
Table 36: The US Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-10
Table 37: The US Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-11
Table 38: The US 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-12
2. CANADA III-13
A.Market Analysis III-13
Overview of the Canadian Animal Health Industry III-13
Imports and Manufacture of Veterinary Biologics III-13
First to Access E. coli 0157:H7 Vaccine III-13
Product Launch III-14
B.Market Analytics III-14
Table 39: Canadian Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-14
Table 40: Canadian Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-15
Table 41: Canadian 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-16
3. JAPAN III-17
Market Analysis III-17
Table 42: Japanese Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-17
Table 43: Japanese Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-18
Table 44: Japanese 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-19
4. EUROPE III-20
A.Market Analysis III-20
Steady Growth Expected for Animal Vaccine Market Due to
Superior Livestock Management III-20
Vaccine Regulations III-20
EU Animal Welfare Strategy III-20
Key Statistical Findings III-21
Table 45: European Pet Market (2014): Estimated Pet
Population by Type of Pets - Cats, Dogs, Birds, Small
Mammals and Aquaria (includes corresponding Graph/Chart) III-21
Table 46: European Antimicrobials Market (2014): Percentage
Share Breakdown of Dollar Sales of Antimicrobials by Type -
Injectable Forms and Oral Forms (includes corresponding
Graph/Chart) III-21
B.Market Analytics III-22
Table 47: European Recent Past, Current and Future Analysis
for Animal Medication Products by Geographic Region/Country -
France, Germany, Italy, UK, Spain, Russia, and Rest of
Europe Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-22
Table 48: European Historic Review for Animal Medication
Products by Geographic Region/ Country - France, Germany,
Italy, UK, Spain, Russia, and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) III-23
Table 49: European 15-Year Perspective for Animal Medication
Products by Geographic Region/Country - Percentage Breakdown
of Dollar Sales for France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe Markets for Years 2006, 2014, and
2020 (includes corresponding Graph/Chart) III-24
Table 50: European Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-25
Table 51: European Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-26
Table 52: European 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-27
4a. FRANCE III-28
A.Market Analysis III-28
Strategic Corporate Development III-28
Key Players III-28
B.Market Analytics III-30
Table 53: French Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-30
Table 54: French Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-31
Table 55: French 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-32
4b. GERMANY III-33
A.Market Analysis III-33
Product Launch III-33
Strategic Corporate Development III-33
Key Players III-33
B.Market Analytics III-35
Table 56: German Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-35
Table 57: German Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-36
Table 58: German 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-37
4c. ITALY III-38
Market Analysis III-38
Table 59: Italian Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-38
Table 60: Italian Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-39
Table 61: Italian 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-40
4d. THE UNITED KINGDOM III-41
A.Market Analysis III-41
Table 62: UK Animal Medication Market: Percentage Share
Breakdown of Sales by Product Type - Endoparasiticides,
Ectoparasiticides, Vaccines, Antimicrobials, Medicines for
Reproductive Problems, Anti-Inflammatories, and Others
(2011-2013) (includes corresponding Graph/Chart) III-41
Table 63: UK Animal Medication Market: Percentage Share
Breakdown of Animal Medication Sales by End-Segment -
Companion Animals, Livestock, and Others/Multi-species
(2011-2013) (includes corresponding Graph/Chart) III-42
Table 64: UK Animal Medication Market: Percentage Share
Breakdown of Animal Medication Sales by Legal Category -
POM-V, POM-VPS, AVM-GSL, NFA-VPS, and SAES (2011-2013)
(includes corresponding Graph/Chart) III-43
Key Statistical Finding III-43
Table 65: UK Pet Market (2011): Estimated Pet Population
(In Million) by Type of Pets - Dogs, Cats, Fish, Rabbits,
Birds and Other Pets (includes corresponding Graph/Chart) III-43
Strategic Corporate Developments III-44
Dechra Pharmaceuticals Plc - A Key Player III-44
B.Market Analytics III-45
Table 66: The UK Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-45
Table 67: The UK Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-46
Table 68: The UK 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-47
4e. SPAIN III-48
Market Analysis III-48
Table 69: Spanish Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-48
Table 70: Spanish Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-49
Table 71: Spanish 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-50
4f. RUSSIA III-51
A.Market Analysis III-51
Russia Mass-Produces Vaccines against Avian Flu III-51
B.Market Analytics III-52
Table 72: Russian Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-52
Table 73: Russian Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-53
Table 74: Russian 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-54
4g. REST OF EUROPE III-55
A.Market Analysis III-55
A Review Of Regional Animal Vaccine Markets III-55
The Netherlands III-55
Denmark III-55
Product Launch III-56
Merck Animal Health (Netherlands) - A Key Player III-57
B.Market Analytics III-58
Table 75: Rest of Europe Recent Past, Current and Future
Analysis for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and
Others) Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-58
Table 76: Rest of Europe Historic Review for Animal
Medication Products by End-Use Segments - Companion Animals
and Farm Animals (Cattle, Pigs and Others) Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-59
Table 77: Rest of Europe 15-Year Perspective for Animal
Medication Products by End-Use Segments - Percentage
Breakdown of Dollar Sales for Companion Animals and Farm
Animals (Cattle, Pigs and Others) for Years 2006, 2014, and
2020 (includes corresponding Graph/Chart) III-60
5. ASIA-PACIFIC III-61
A.Market Analysis III-61
Current & Future Analysis III-61
B.Market Analytics III-61
Table 78: Asia-Pacific Recent Past, Current and Future
Analysis for Animal Medication Products by Geographic
Region/Country - China, India and Rest of Asia-Pacific
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-61
Table 79: Asia-Pacific Historic Review for Animal Medication
Products by Geographic Region/ Country - China, India and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2006 through
2012 (includes corresponding Graph/Chart) III-62
Table 80: Asia-Pacific 15-Year Perspective for Animal
Medication Products by Geographic Region/Country -
Percentage Breakdown of Dollar Sales for China, India and
Rest of Asia-Pacific Markets for Years 2006, 2014, and 2020
(includes corresponding Graph/Chart) III-63
Table 81: Asia-Pacific Recent Past, Current and Future
Analysis for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and
Others) Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-64
Table 82: Asia-Pacific Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-65
Table 83: Asia-Pacific 15-Year Perspective for Animal
Medication Products by End-Use Segments - Percentage
Breakdown of Dollar Sales for Companion Animals and Farm
Animals (Cattle, Pigs and Others) for Years 2006, 2014, and
2020 (includes corresponding Graph/Chart) III-66
5a. CHINA III-67
A.Market Analysis III-67
Growing Pet Industry Holds Promise III-67
Increased Livestock Output Lead to Higher Vaccine Demand III-67
Threat of Avian Influenza Outbreaks Creates Market for
Effective Vaccine III-68
Demand for Higher-Quality Swine Fever Vaccine III-68
Demand for Effective PRRS Vaccines by Foreign Manufacturers III-69
Highly Consolidated Chinese Animal Vaccine Market III-69
Strategic Corporate Development III-69
B.Market Analytics III-70
Table 84: Chinese Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-70
Table 85: Chinese Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-71
Table 86: Chinese 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-72
5b. INDIA III-73
A.Market Analysis III-73
Animal Vaccination Market Scenario III-73
Major Players III-73
B.Market Analytics III-74
Table 87: Indian Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-74
Table 88: Indian Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-75
Table 89: Indian 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-76
5c. REST OF ASIA-PACIFIC III-77
A.Market Analysis III-77
Review of Select Markets III-77
Australia III-77
A Note on Australian Veterinary Therapeutics Market III-77
Key Statistical Findings III-77
Table 90: Australian Pet Market (2014): Estimated Pet
Population by Type of Pets - Dogs, Cats, Fish, Birds and
Other Pets (includes corresponding Graph/Chart) III-77
Table 91: Australian Pet Healthcare Market (2014):
Percentage Share Breakdown of Annual Consumer Expenditure
on Pet Health by Service Type (includes corresponding
Graph/Chart) III-78
Table 92: Australian Pet Healthcare Market (2014):
Percentage Share Breakdown of Annual Consumer Expenditure
on Veterinary Services by Pet Type - Dogs, Cats and Other
Pets (includes corresponding Graph/Chart) III-78
Table 93: Australian Pet Healthcare Market (2014):
Percentage Breakdown of Annual Sales of Veterinary
Chemicals by Product Type - Parasiticides, Immunotherapy,
Nutritional and Metabolism, Antibiotics and Others
(includes corresponding Graph/Chart) III-78
Taiwan III-79
Taiwan's Animal Healthcare Industry under Scan III-79
Strategic Corporate Development III-79
B.Market Analytics III-80
Table 94: Rest of Asia-Pacific Recent Past, Current and
Future Analysis for Animal Medication Products by End-Use
Segments - Companion Animals and Farm Animals (Cattle, Pigs
and Others) Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-80
Table 95: Rest of Asia-Pacific Historic Review for Animal
Medication Products by End-Use Segments - Companion Animals
and Farm Animals (Cattle, Pigs and Others) Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-81
Table 96: Rest of Asia-Pacific 15-Year Perspective for
Animal Medication Products by End-Use Segments - Percentage
Breakdown of Dollar Sales for Companion Animals and Farm
Animals (Cattle, Pigs and Others) for Years 2006, 2014, and
2020 (includes corresponding Graph/Chart) III-82
6. LATIN AMERICA III-83
A.Market Analysis III-83
Current & Future Analysis III-83
B.Market Analytics III-83
Table 97: Latin American Recent Past, Current and Future
Analysis for Animal Medication Products by Geographic
Region/Country - Brazil, Mexico and Rest of Latin America
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-83
Table 98: Latin American Historic Review for Animal
Medication Products by Geographic Region/Country - Brazil,
Mexico and Rest of Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-84
Table 99: Latin American 15-Year Perspective for Animal
Medication Products by Geographic Region/Country -
Percentage Breakdown of Dollar Sales for Brazil, Mexico and
Rest of Latin America Markets for Years 2006, 2014, and 2020
(includes corresponding Graph/Chart) III-85
Table 100: Latin American Recent Past, Current and Future
Analysis for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and
Others) Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-86
Table 101: Latin American Historic Review for Animal
Medication Products by End-Use Segments - Companion Animals
and Farm Animals (Cattle, Pigs and Others) Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-87
Table 102: Latin American 15-Year Perspective for Animal
Medication Products by End-Use Segments - Percentage
Breakdown of Dollar Sales for Companion Animals and Farm
Animals (Cattle, Pigs and Others) for Years 2006, 2014, and
2020 (includes corresponding Graph/Chart) III-88
6a. BRAZIL III-89
A.Market Analysis III-89
Key Statistical Finding III-89
Table 103: Brazilian Animal Healthcare Market (2011):
Percentage Breakdown of Market Share by Type of Companies -
Multinational and National (includes corresponding
Graph/Chart) III-89
B.Market Analytics III-90
Table 104: Brazilian Recent Past, Current and Future
Analysis for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and
Others) Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-90
Table 105: Brazilian Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-91
Table 106: Brazilian 15-Year Perspective for Animal
Medication Products by End-Use Segments - Percentage
Breakdown of Dollar Sales for Companion Animals and Farm
Animals (Cattle, Pigs and Others) for Years 2006, 2014, and
2020 (includes corresponding Graph/Chart) III-92
6b. MEXICO III-93
Market Analysis III-93
Table 107: Mexican Recent Past, Current and Future Analysis
for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and Others)
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-93
Table 108: Mexican Historic Review for Animal Medication
Products by End-Use Segments - Companion Animals and Farm
Animals (Cattle, Pigs and Others) Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006
through 2012 (includes corresponding Graph/Chart) III-94
Table 109: Mexican 15-Year Perspective for Animal Medication
Products by End-Use Segments - Percentage Breakdown of
Dollar Sales for Companion Animals and Farm Animals (Cattle,
Pigs and Others) for Years 2006, 2014, and 2020 (includes
corresponding Graph/Chart) III-95
6c. REST OF LATIN AMERICA III-96
Market Analysis III-96
Table 110: Rest of Latin American Recent Past, Current and
Future Analysis for Animal Medication Products by End-Use
Segments - Companion Animals and Farm Animals (Cattle, Pigs
and Others) Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-96
Table 111: Rest of Latin American Historic Review for Animal
Medication Products by End-Use Segments - Companion Animals
and Farm Animals (Cattle, Pigs and Others) Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-97
Table 112: Rest of Latin American 15-Year Perspective for
Animal Medication Products by End-Use Segments - Percentage
Breakdown of Dollar Sales for Companion Animals and Farm
Animals (Cattle, Pigs and Others) for Years 2006, 2014, and
2020 (includes corresponding Graph/Chart) III-98
7. REST OF WORLD III-99
Market Analysis III-99
Table 113: Rest of World Recent Past, Current and Future
Analysis for Animal Medication Products by End-Use Segments -
Companion Animals and Farm Animals (Cattle, Pigs and
Others) Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-99
Table 114: Rest of World Historic Review for Animal
Medication Products by End-Use Segments - Companion Animals
and Farm Animals (Cattle, Pigs and Others) Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2006 through 2012 (includes corresponding Graph/Chart) III-100
Table 115: Rest of World 15-Year Perspective for Animal
Medication Products by End-Use Segments - Percentage
Breakdown of Dollar Sales for Companion Animals and Farm
Animals (Cattle, Pigs and Others) for Years 2006, 2014, and
2020 (includes corresponding Graph/Chart) III-101
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 122 (including Divisions/Subsidiaries - 144)
The United States (62)
Canada (3)
Japan (1)
Europe (37)
- France (4)
- Germany (7)
- The United Kingdom (7)
- Italy (2)
- Rest of Europe (17)
Asia-Pacific (Excluding Japan) (30)
Latin America (5)
Africa (2)
Middle East (4)
Read the full report: http://www.reportlinker.com/p0960410-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article